HA

Hena Akhtar

Active Director Director DIN 10827476
DIN 10827476 First appointment Nov 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value •••• Premium profile

About Hena Akhtar

Data last updated:

Hena Akhtar is a Director at Endcure Pharma Private Limited (since 2024). The company operates in Healthcare. Endcure Pharma Private Limited reported revenue of ₹12.5 Lakh (FY 2025).

DIN 10827476
Primary Designation Director
Industry Healthcare
First Appointment 05 Nov 2024
Oldest Company Age 4 yrs
Largest company Endcure Pharma Private Limited · ₹12.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Endcure Pharma Private Limited U85100MH2022PTC381177
Director05 Nov 20242022₹12.5 Lakh (FY 2025)Active

Board colleagues of Hena Akhtar

NameDINCompanyDesignation
Shamapravin09582385Endcure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Endcure Pharma Private Limited
Premium access

Shareholding and investment profile for Hena Akhtar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hena Akhtar

Hena Akhtar currently holds 1 directorship: Endcure Pharma Private Limited (Director, since 05 Nov 2024, revenue ₹12.5 Lakh (FY 2025)).

Hena Akhtar was first appointed on 05 Nov 2024 as Director at Endcure Pharma Private Limited.

The current boards of Hena Akhtar's companies include Shamapravin (Endcure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available